The most recent trading session ended with Moderna (MRNA) standing at $57.73, reflecting a -0.96% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.77%.
Moderna doses first participant in phase 3 trial of mRNA norovirus vaccine, mRNA-1403: Cambridge, Massachusetts Thursday, October 3, 2024, 12:00 Hrs [IST] Moderna, Inc, a global l ...
This growth has continued into 2024, with the rising value of licensing agreements reflecting growing confidence in this technology beyond application in vaccines. Global sales for innovator mRNA ...
Engineers have discovered a simple and inexpensive means of directing lipid nanoparticles (LNPs), the revolutionary molecules that delivered the COVID-19 vaccines, to target specific tissues, ...
The Hong Kong stock market’s pharmaceutical sector has seen a strong rebound recently. Among them, AIM Vaccine Co., Ltd. (06660.HK) led the rise in the ...